UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021080 |
|---|---|
| Receipt number | R000024239 |
| Scientific Title | A phase I study of lenvatinib for unresectable adenoid cystic carcinoma of the salivary gland |
| Date of disclosure of the study information | 2016/02/18 |
| Last modified on | 2020/08/25 22:08:22 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/02/17 23:52:00 | ||
| 2 | Update | 2016/03/02 17:31:31 | Primary outcomes Primary outcomes |
|
| 3 | Update | 2016/03/02 17:33:39 | Tel1 Email1 |
|
| 4 | Update | 2016/04/14 15:27:26 | UMIN ID1 |
|
| 5 | Update | 2017/08/24 17:59:34 | Last name of contact person Last name of contact person Name of primary person or sponsor Organization |
|
| 6 | Update | 2017/08/24 18:01:54 | Recruitment status |
|
| 7 | Update | 2020/08/25 22:04:29 | Date of IRB |
|
| 8 | Update | 2020/08/25 22:05:05 | Number of participants that the trial has enrolled |
|
| 9 | Update | 2020/08/25 22:08:22 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
